Skip to main content

Table 4 The osteoporosis incidence and risk in keloids patients with comorbidity

From: The association between keloid and osteoporosis: real-world evidence

Variables

Patients with keloids

Patients without keloids

Compared with non-keloids controls

Osteoporosis

PY

Rate

Osteoporosis

PY

Rate

Adjusted HR(95% CI)a

Hyperlipidemia

 No

60

38,378.15

1.56

251

451,138.90

0.57

2.48 (1.85–3.33)*

 Yes

118

10,659.27

11.07

336

60,212.42

5.58

2.74 (2.20–3.42)*

Stroke

 No

143

47,551.35

3.01

501

504,095.08

0.99

2.59 (2.13–3.16)*

 Yes

35

1486.07

23.55

86

7256.23

11.85

2.90 (1.95–4.33)*

Chronic liver disease

 No

81

35,472.65

2.28

338

439,113.30

0.77

2.34 (1.82–3.01)*

 Yes

97

13,564.77

7.15

249

72,238.01

3.45

2.99 (2.34–3.81)*

Depression

 No

125

42,773.81

2.92

467

478,243.51

0.98

2.45 (1.98–3.02)*

 Yes

53

6263.61

8.46

120

33,107.81

3.62

3.30 (2.37–4.61)*

  1. PYs Person-year; Rate, incidence rate in per 1000 person-years; 95% CI 95% Confidence interval; HR Hazard ratio
  2. a Model adjusted for age, gender, Charlson Comorbidity Index and relevant comorbidities
  3. * P< 0.001